Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our “Public Policy Weekly* Health Care Newsletter” in which we compile the latest Health care policy news and legislation. *Please note that we...more
6/21/2018
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Healthcare ,
HELP ,
Hospitals ,
Medicaid ,
Medicare ,
National Institute of Health (NIH) ,
Opioid ,
Pharmaceutical Industry ,
Proposed Legislation ,
Secretary of HHS ,
Senate Finance Committee ,
Substance Abuse ,
Trump Administration
Foley’s Bipartisan Public Policy Team is pleased to share our “Public Policy Health Care Newsletter” in which we compile the latest health care policy news and legislation. *Please note that we publish this newsletter only...more
6/12/2018
/ Affordable Care Act ,
Appropriations Bill ,
Centers for Medicare & Medicaid Services (CMS) ,
Cybersecurity ,
Department of Health and Human Services (HHS) ,
Federal Budget ,
Food and Drug Administration (FDA) ,
GAO ,
HELP ,
Legislative Agendas ,
Legislative Committees ,
Medicare ,
Medicare Part D ,
National Institute of Health (NIH) ,
Opioid ,
Pharmaceutical Industry ,
Prescription Drugs ,
Preventive Health Care ,
Substance Abuse ,
Trump Administration ,
Ways and Means Committee
Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our “Public Policy Weekly Health Care Newsletter” in which we compile the latest health care policy news and legislation....more
5/29/2018
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
DEA ,
Department of Health and Human Services (HHS) ,
Drug & Alcohol Abuse ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Health Care Providers ,
Infectious Diseases ,
Legislative Agendas ,
Medicare Part D ,
Opioid ,
Pharmaceutical Industry ,
Prescription Drugs ,
Telemedicine ,
Trump Administration
Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our “Public Policy Weekly Health Care Newsletter” in which we compile the latest health care policy news and legislation.*Please note that we...more
5/21/2018
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Federal Funding ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare Reform ,
HELP ,
Legislative Agendas ,
Medicaid ,
Medicare ,
Opioid ,
Prescription Drugs ,
Section 340B ,
Trump Administration
Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our second “Public Policy Weekly* Health Care Newsletter” in which we compile the latest health care policy news and legislation.
Please...more
5/14/2018
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
DEA ,
Department of Health and Human Services (HHS) ,
Department of Veterans Affairs ,
Drug Pricing ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Medicaid ,
Medicare Part C ,
Mental Health ,
National Institute of Health (NIH) ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Agenda ,
Section 340B ,
Social Security Act ,
Trade Policy ,
Trump Administration
Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to introduce “This Week in Health Care Policy,” a new weekly publication providing a compilation of the latest health care policy news and legislation....more
5/1/2018
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Department of Veterans Affairs ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Information Technology ,
Legislative Agendas ,
Opioid ,
Pharmaceutical Industry ,
Physicians ,
Prescription Drugs ,
Section 340B ,
Telemedicine
While health reform and a Supreme Court nomination may dominate the news cycle in the early days of the Trump administration, tax reform is already taking shape behind the scenes. With committee staff digging into the...more
1/27/2017
/ Affordable Care Act ,
Chevron Deference ,
Congressional Review Act ,
Consumer Financial Protection Bureau (CFPB) ,
Deregulation ,
Dodd-Frank ,
Financial Regulatory Reform ,
Financial Services Industry ,
Legislative Agendas ,
Repeal ,
Tax Reform ,
Trump Administration
Few things are certain leading up to Donald Trump’s presidency. But there is no question that environmental and energy policy will take center stage in the days – perhaps hours – following his inauguration....more
1/20/2017
/ Clean Power Plan ,
Climate Action Plan ,
Coal Ash ,
Endangered Species Act (ESA) ,
Energy Policy ,
Environmental Policies ,
Environmental Protection Agency (EPA) ,
Fracking ,
Keystone XL Pipeline ,
Paris Agreement ,
Production Tax Credit ,
Renewable Energy ,
Trump Administration
Politically, 2016 is a year few of us will soon forget — and 2017 could be just as memorable, as the focus shifts from the campaign trail to Capitol Hill. With Congress adjourned for the year and the framework of the Trump...more
12/23/2016
/ Affordable Care Act ,
Budget Reconciliation ,
Deregulation ,
Dodd-Frank ,
Environmental Policies ,
Healthcare Reform ,
Legislative Agendas ,
Political Parties ,
Popular ,
Tax Reform ,
Transition Team ,
Trump Administration ,
Water ,
WRDA
With the 2016 election in the rearview mirror, manufacturers must be mindful of the early initiatives you can expect from Congress and the new administration. With a return to one-party rule, the coming congressional term is...more
11/29/2016
/ Affordable Care Act ,
Barack Obama ,
Clean Air Act ,
Climate Change ,
Consumer Financial Protection Bureau (CFPB) ,
Cuba ,
Executive Orders ,
Financial Services Industry ,
Iran ,
Keystone XL Pipeline ,
NAFTA ,
Presidential Elections ,
Repeal ,
Tax Reform ,
Transition Team ,
Trump Administration